<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_UCLouvain_Design skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:UCLouvain/Design</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><P><NAV class="site-header sticky-top py-1 navbar-center"><UL class="navbar-nav mr-auto container d-flex flex-column flex-md-row justify-content-between" id="list_menu"><LI class="nav-item dropdown"><A class="nav-link dropdown-toggle" href="#" id="navbarDropdown" role="button" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false">
        Our project
      </A><DIV class="dropdown-menu" aria-labelledby="navbarDropdown"><A class="dropdown-item" href="https://2018.igem.org/Team:UCLouvain/Context">Context</A><A class="dropdown-item" href="https://2018.igem.org/Team:UCLouvain/Description">Description</A><A class="dropdown-item" href="https://2018.igem.org/Team:UCLouvain/Design">Design</A><A class="dropdown-item" href="https://2018.igem.org/Team:UCLouvain/Experiments">Experiments</A><A class="dropdown-item" href="https://2018.igem.org/Team:UCLouvain/Results">Results</A><A class="dropdown-item" href="https://2018.igem.org/Team:UCLouvain/Demonstrate">Demonstrate</A><A class="dropdown-item" href="https://2018.igem.org/Team:UCLouvain/Improve">Perspectives</A></DIV></LI><LI class="nav-item dropdown"><A class="nav-link dropdown-toggle" href="#" id="navbarDropdown" role="button" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false">
        In the lab
      </A><DIV class="dropdown-menu" aria-labelledby="navbarDropdown"><A class="dropdown-item" href="https://2018.igem.org/Team:UCLouvain/Notebook">Notebook</A><A class="dropdown-item" href="https://2018.igem.org/Team:UCLouvain/Attributions">Attributions</A><A class="dropdown-item" href="https://2018.igem.org/Team:UCLouvain/InterLab">InterLab</A></DIV></LI><LI class="nav-item dropdown"><A class="nav-link dropdown-toggle" href="#" id="navbarDropdown" role="button" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false">
        Parts
      </A><DIV class="dropdown-menu" aria-labelledby="navbarDropdown"><A class="dropdown-item" href="https://2018.igem.org/Team:UCLouvain/Parts">Overview</A><A class="dropdown-item" href="https://2018.igem.org/Team:UCLouvain/Basic_Part">Basic parts</A><A class="dropdown-item" href="https://2018.igem.org/Team:UCLouvain/Composite_Part">Composite parts</A></DIV></LI><LI class="nav-item"><A class="nav-link smallcaps" href="https://2018.igem.org/Team:UCLouvain/Safety">Safety</A></LI><LI class="nav-item dropdown"><A class="nav-link dropdown-toggle" href="#" id="navbarDropdown" role="button" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false">
        Human practices
      </A><DIV class="dropdown-menu" aria-labelledby="navbarDropdown"><A class="dropdown-item" href="https://2018.igem.org/Team:UCLouvain/Human_Practices">Integrated Human Practices</A><A class="dropdown-item" href="https://2018.igem.org/Team:UCLouvain/Public_Engagement">Education &amp; Engagement</A></DIV></LI><LI class="nav-item dropdown"><A class="nav-link dropdown-toggle" href="#" id="navbarDropdown" role="button" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false">
        Awards
      </A><DIV class="dropdown-menu" aria-labelledby="navbarDropdown"><A class="dropdown-item" href="https://2018.igem.org/Team:UCLouvain/awards/Best_therapeutic">Best therapeutic project</A><A class="dropdown-item" href="https://2018.igem.org/Team:UCLouvain/Entrepreneurship">Entrepreneurship</A><A class="dropdown-item" href="https://2018.igem.org/Team:UCLouvain/Public_Engagement">Public Engagement</A><A class="dropdown-item" href="https://2018.igem.org/Team:UCLouvain/Human_Practices">Integrated Human Practices</A></DIV></LI><LI class="nav-item dropdown"><A class="nav-link dropdown-toggle" href="#" id="navbarDropdown" role="button" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false">
        About us
      </A><DIV class="dropdown-menu" aria-labelledby="navbarDropdown"><A class="dropdown-item" href="https://2018.igem.org/Team:UCLouvain/Team">Our Team</A><A class="dropdown-item" href="https://2018.igem.org/Team:UCLouvain/University">Our University</A><A class="dropdown-item" href="https://2018.igem.org/Team:UCLouvain/Collaborations">iGEM Collaborations</A><A class="dropdown-item" href="https://2018.igem.org/Team:UCLouvain/Sponsor">Our Sponsors</A><A class="dropdown-item" href="https://2018.igem.org/Team:UCLouvain/Partners">Our Partners</A></DIV></LI><LI class="nav-item"><A class="nav-link smallcaps" href="https://igem.org/2018_Judging_Form?team=UCLouvain">Judging form</A></LI></UL></NAV></P><DIV style="margin-top: 2%"><P class="bordgauche" style="font-size:100px; color:#16A2B8;"> Design</P><DIV class="container"><DIV class="row"><DIV class="col-12"><H3>Reporter Plasmids
          </H3>
            Our reporter plasmids were designed with the iGem’s BioBrick system. The plasmid pSB4A5 and pSB4K5 carrying the Amp and Kan resistance gene. A low copy ORI and the GFP or RFP gene where inserted. (See Experimental section)

          <H3>Killer Plasmids</H3>

            Our two plasmids - one targeting the RFP gene, one targeting the Ampicillin gene - where designed from the mobilizable pK18mob plasmid (carrying the KanR gene), received from the C.E.N. The Cas9 gene (and promoter and terminator) was
            cutted and inserted in this pK18mob plasmid, followed by an insertion of a synthetic cassette containing a sgRNA (Crispr/Cas9 system), targeting the RFP gene and the Ampicillin resistance gene.

          <H3>Killer Plasmid : design and construction
          </H3><H4>Design</H4>
            We received a mobilizable plasmid (pK18mob) carrying Kanamycin resistance gene and OriT. Our purpose in to combine its conjugative capabilities with the Crispr/Cas9 system, so the final killer plasmid will be able to conjugate and to cut
            a target gene (the RFP gene and Ampicillin resistance gene). So, from the pK18mob, we have inserted the Crispr/Cas9 system : the Cas9 gene (with its promoter and terminator), and a synthetic single guide RNA.
            We have design two single guide RNA, to target the RFP gene and the Ampicillin resistance gene by Crispr/Cas9 system. The sgRNA sequence was design in Benchling, and carry : cut/ligation sites at extremities, promoter pJ23119, the guide
            RNA and the terminator. Three DAM site (GATC) was cleaned, to avoid methylation. This sequence was synthetized by IDT.


          <DIV style="text-align: center"><P class="legend" style="text-align:center;">Schematic representation of our system. Here, our killer plasmid conjugate with the recipient bacteria and a gene present in chromosome is cut.</P></DIV><H4>Killer Strain</H4>
            The donor strain carrying the killer plasmid is S17-1, who have the RP4 conjugative machinery. With this strain, our killer plasmid can conjugate with other gram negative bacteria, and transfer into it our killer Crispr/Cas9 system.


        </DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>